Exporter

EN
FR
Irinotecan
Statut de médicament essentiel
Description générale
Irinotecan is an antineoplastic topoisomerase I inhibitor used in the treatment of colorectal cancer.
INN
Irinotecan
Codes ATC
L01CE02
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté pour la première fois en 2015 (TRS 994) pour Malignant neoplasm metastasis in large intestine
Wikipédia
Irinotecan
DrugBank
Irinotecan
Recommandations
Section
Cytotoxic medicines
  • Parenteral > General injections > IV: 40 mg per 2 mL in 2 mL vial; 100 mg per 5 mL in 5 mL vial; 500 mg per 25 mL in 25 mL vial
Indications
Malignant neoplasm metastasis in large intestine Malignant neoplasms of kidney, except renal pelvis Rhabdomyosarcoma primary site